Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
The use of intrapleural therapy with tissue plasminogen activator and DNase improves outcomes in patients with complicated pleural space infections. However, little data exists for the use of combination intrapleural therapy after the initial dosing period of six doses. We sought to describe the saf...
Main Authors: | Jason R. McClune, Candice L. Wilshire, Jed A. Gorden, Brian E. Louie, Alexander S. Farviar, Michael J. Stefanski, Eric Vallieres, Ralph W. Aye, Christopher R. Gilbert |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2016/9796768 |
Similar Items
-
Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection
by: Benoît Bédat, et al.
Published: (2019-09-01) -
Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
by: M. Faisal, et al.
Published: (2020-01-01) -
Low dose intrapleural alteplase and pulmozyme (DNase) in two post-surgical patients with pleural sepsis
by: M. Faisal, et al.
Published: (2020-01-01) -
Bronchopleural communication following intrapleural doses of tPA/DNase for empyema
by: Bapti Roy, et al.
Published: (2020-10-01) -
Short‐course intrapleural alteplase and DNase in complex effusion with bleeding risk
by: Xiong Khee Cheong, et al.
Published: (2020-10-01)